Blood

923 papers64 directions
Blood is a long-standing publication venue for hematological research, with active contributions in the corpus spanning from 1973 through 2026. In the context of machine learning and artificial intelligence, the venue focuses on the integration of computational methods with clinical hematology to improve patient outcomes. Its content frequently addresses the development of independent biomarkers for disease prognosis, risk stratification for precision treatment selection, and the identification of molecular regulatory axes to overcome chemotherapy resistance. The venue publishes research on the application of AI-based diagnostic tools, such as those used for identifying myelodysplastic syndromes, and the use of integrated profiling to predict treatment responses in conditions like acute myeloid leukemia. Recent papers also explore technical frameworks for data science in medicine, including the generation of synthetic data over federated learning systems to accelerate personalized medicine. This research often utilizes large-scale data sources, such as nationwide electronic health record databases, to conduct epidemiological studies on conditions like venous thromboembolism. In the broader research community, Blood serves as a platform for addressing the statistical and methodological challenges of applying data science to specialized medicine. This includes investigating the generalizability gap in single-center clinical research and managing statistical power challenges in rare disease studies. Prolific contributors such as Zhixiang Shen, Aaron D. Schimmer, and Véronique Voisin highlight the venue's role in bridging bridging strategies for stem cell transplantation with advanced predictive modeling and microvascular visualization techniques.

Papers by Year

2026 4
2025 99
2024 129
2023 83
2022 72
2021 31
2020 44
2019 40
2018 42
2017 17
2016 30
2015 30
2014 26
2013 30
2012 33
2011 32
2010 24
2009 31
2008 25
2007 13
2006 17
2005 22
2004 15
2003 6
2002 4
2001 8
2000 1
1999 2
1998 2
1997 4
1996 1
1995 1
1993 1
1990 4
1988 1
1987 1
1974 1
1973 1

Top Research Directions

Research directions most represented by papers from this venue.

Viscoelastic Monitoring of Whole Blood Coagulation 2
The Non-Additive Toxicity of Multi-Modal Adjunctive Therapies 2
Targeting the Mechanisms of Cancer Stem Cell Resistance 2
Overcoming Data Scarcity in Rare Disease Research 2
Transcriptional Artifacts and Selective Loss from Tissue Dissociation 1
Quantifying Clinical Relevance Beyond Statistical Significance 1
Molecular Clonal Tracking via Immune Repertoire Sequencing 1
Discovering Driver Pathways via Mutational Mutual Exclusivity 1
The Structural Convergence of Adaptive Immune Repertoires 1
Predicting Therapeutic Efficacy Before Morphological Change 1
Synergistic Innate Immune Activation via Combinatorial Adjuvants 1
Genetic Lineage Tracing for Mapping Cellular Ancestry 1
Mechanisms of Metabolic Drug-Drug Interactions 1
Bioorthogonal Labeling and Chemical Proteomics for Target Identification 1
The Dynamics of Dose Dependent Therapeutic Efficacy 1

Top Authors

AuthorPapers
Zhixiang Shen38
Jane E. Barker19
Hongyu An15
Barbara D. Lam12
Zinaida Good12
Mikel Hernaez11
Bita Sahaf9
Lori Muffly9
Matthew J. Frank9
James Nichols8
Jorge J. Nieva8
Allon M Klein7
Filippo Utro6
Jianqiang Li6
Kahn Rhrissorrakrai6
Meong Hi Son6
Moksha H. Desai6
Saurabh Dahiya6
Zachary Ehlinger6
Andrew R. Rezvani5

Impactful Papers

Papers from this venue that shaped research clusters.

Foundational

Influential

Related Venues

Venues with the most similar research cluster distributions.

Papers

TitleYear
Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell2024
Hemoadsorption and Coagulation Systemic Rebalance in Patients Undergoing Nonelective Cardiac Surgery and Treated with Antithrombotics2024
Identification of Novel Genes Underlying Human AML Expansion at Relapse from Chemotherapy2024
Identifying Patients with Erythrocytosis Not Requiring JAK2 Testing: External Validation and Decision Analysis of the Jakpot Prediction Rule2024
In Vivo Sickle Cell Blood Rheology in Humans with Ventral Tongue Microscopy2024
Imbalanced Expression of TACI Isoforms Regulated By TNFRSF13B Variants Promotes the Progression of Epstein-Barr Virus-Associated Lymphoproliferative Diseases2024
Impact of Different Therapeutic Regimen on Prognosis in CEBPAbZIP-Inf Acute Myeloid Leukemia2024
Impact of Febrile Neutropenia on Mobilization Efficacy in Multiple Myeloma Patients and Post-Transplant Infection Risk in Lymphoma Patients: Insights from Real-World Multicenter Data2024
Impact of Platelet Transfusion and Bleeding Risk Stratification in Patients with Immune Thrombocytopenia before Procedures: A Nationwide Population-Based Cohort Study2024
Improved Outcomes with Venetoclax in Combination with Mitoxantrone Liposome and Cytarabine for Myeloid Sarcoma By Preliminary Observations2024
Incidence, Time to Diagnosis, and Therapeutic Landscape of Aplastic Anemia: Results from a Large United States Claims Database2024
Inhibition of TGF-β in Bone Marrow Endothelial Progenitor Cells Promotes Hematopoietic Recovery in Acute Myeloid Leukemia after Chemotherapy2024
Initial Results of a First-in-Human, Phase I Study Point-of-Care Manufacturing of Trispecific CAR-T Cells Targeting CD19/20/22 in B-Cell Malignancies2024
Intracranial aneurysms in sickle cell disease are associated with hemodynamic stress and anemia2024
iPSC-Derived CAR-Gamma Delta T with Novel Combinatorial KO Demonstrated Extended Longevity and Profound Anti-Tumor Efficacy without Cytokine Support in Preclinical Studies2024
SRSF2 Mutation Cooperates with ASXL1 Mutation to Promote the Development of Myeloproliferative Variant of Chronic Myelomonocytic Leukemia2024
Karyotype AI for Precision Oncology2024
Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)2024
Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial2024
Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma2024
Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis2024
Managing Hypersensitivity Reactions after Asparaginase Treatment: A Systematic Literature Review2024
MDS-AML Aggregative Risk Classification System (MARCS): A Novel, Enhanced Risk Stratification System Derived from the Combined Unsupervised Analysis of 7,480 MDS and AML Patients2024
Molecular Biology Study of Primary Immuno-Privileged Lymphomas2024
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma2024
Multi-Omics Immune Profiling of Graft-Versus-Host Disease (GvHD) in Humans2024
Multi-Site Randomized Trial of a Collaborative Palliative and Oncology Care Model for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Receiving Non-Intensive Therapy2024
Mutation-Specific Differences in the Relationship between Obesity and Clonal Hematopoiesis, with a Focus on JAK2V617F and MPN Prevention2024
Novel Natural Ligand Chimeric Antigen Receptors (CARs) Targeting CD70 with a Redesigned CD27 Binding Interface Provide Enhanced Potency Against Acute Myeloid Leukemia2024
Obinutuzumab Is a Promising Alternative for the Treatment of Relapsed or Refractory Autoimmune Hematological Disorders2024
Optimized Multi-Class VTE-BERT Large Language Model for Prediction of Cancer Associated Thrombosis Phenotype2024
Optimized Recombinant Human Thrombopoietin(rhTPO) Regimen Versus Eltrombopag for Pre-Treated Patients with Primary Immune Thrombocytopenia: Interim Results from a Prospective, Multicenter, Randomized 2024
Outcomes in Patients with Cancer-Associated Venous Thromboembolism Receiving Immune Checkpoint Inhibitors: A Matched Cohort Study2024
Pathogenesis and Clinical Relevance of Diffuse Large B-Cell Lymphoma Proteogenotypes2024
PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation2024
Peripheral Blood Smear-Based Deep Learning to Predict Cancer-Associated Thrombosis2024
Peripheral human red blood cell development in human immune system mouse model with heme oxygenase-1 deficiency2024
Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Hbbd3th β-Thalassemia Mouse Model2024
Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Mouse MDS Model of an Inducible Mutant c-Myc Knock-in2024
Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Rat 5/6 Nephrectomy Model2024
Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in Sprague Dawley Rats2024
Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in Townes SCD Mouse Model2024
Platelet proteomic profiling reveals potential mediators of immunothrombosis and proteostasis in myeloproliferative neoplasms2024
Preliminary Investigation of the Efficacy and Safety of Zanubrutinib in Combination with R-Chemo As First-Line Therapy Inpatients with Newly Diagnosed Mantle Cell Lymphoma2024
Prognosis Prediction and Treatment Recommendation for Follicular Lymphoma: Enhancing Decision-Making2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems2024
Progression-Free Survival Improvement of Localized Ocular Adnexal MALT Lymphoma Patients with Residual Lesions: Comparative Outcome of Postoperative Treatment Versus Watchful Waiting2024
Protein and Gene Levels of DNAJC21 and RNF5 Proven to be Novel Drug Targets for Immune Thrombocytopenia: Insights from Mendelian Randomization-Based Post-GWAS Research2024
Proteolytic Control and Therapeutic Targeting of Oncogenic Gene Expression in Acute Myeloid Leukemia2024
Real World First-Line Treatment Strategies and Outcomes in TP53 Mutated and Unmutated Mantle Cell Lymphoma2024

« prev Page 4/19 next »